Free shipping on orders over $149
SafeRxPills - Online Pharmacy
These products are intended for personal use only. We are not licensed by the FDA.
Back to BlogMen's Health

Tadalafil for Erectile Dysfunction and an Enlarged Prostate (BPH): What Daily 5 mg Does

S

SafeRxPills Pharmacy Team

Our pharmacy team consists of certified pharmacists and medical writers with 10+ years of experience in pharmaceutical sciences.

May 18, 202620 min read
Last updated: October 17, 2026
Share:
In this article (21 sections)

Tadalafil is best known as Cialis, an erectile dysfunction (ED) tablet. It is also the only PDE5 inhibitor approved in the US for the urinary symptoms of an enlarged prostate, known as benign prostatic hyperplasia (BPH). Many men in their fifties and sixties have both problems at once, and the same 5 mg daily tablet is approved for that combination too.

This guide covers only that use: tadalafil 5 mg once a day for BPH symptoms, alone or together with ED. It sets out what the US label trials measured, how tadalafil compares with tamsulosin, why the label does not recommend combining it with alpha-blockers for BPH, what happens when it is started with finasteride, and where guidelines disagree. Every number comes from the US Cialis label or a published trial, listed at the end. For as-needed versus daily dosing in ED alone, see our generic Cialis guide.

The short answer

In three 12-week US label trials, tadalafil 5 mg once daily lowered the International Prostate Symptom Score (IPSS) by 4.8 to 6.1 points, against 2.2 to 3.8 points on placebo. That is an extra 2.0 to 2.6 points on a 0 to 35 scale. In men who had both ED and BPH, the same tablet also raised the erectile function score by 6.5 points versus 1.9 on placebo. Urine flow rate did not improve more than placebo in the label trials. In one head-to-head trial, tadalafil and tamsulosin eased urinary symptoms by similar amounts, and only tadalafil helped erections. The US label does not recommend taking tadalafil with an alpha-blocker such as tamsulosin for BPH. UK NICE guidance says not to offer PDE5 inhibitors solely for urinary symptoms outside a trial, so advice depends on where you live.

Why an erection tablet affects the prostate

Tadalafil blocks an enzyme called phosphodiesterase type 5 (PDE5). In the penis this raises a chemical messenger, cyclic GMP, that relaxes smooth muscle and lets blood flow in during arousal. The Cialis label notes that the same effect on cyclic GMP is seen in the smooth muscle of the prostate, the bladder and their blood supply.

The label is careful on one point: "The mechanism for reducing BPH symptoms has not been established." The trials show that symptom scores improve. They do not show exactly why, and they do not show that the prostate gets smaller. That sets tadalafil apart from finasteride, which works on the prostate itself by lowering a hormone called dihydrotestosterone (DHT).

What BPH symptoms are and how trials score them

BPH is a non-cancerous enlargement of the prostate. As it grows it can press on the urethra and change how the bladder works. The symptoms fall into two groups: storage symptoms (going often, urgency, getting up at night) and voiding symptoms (weak stream, stopping and starting, straining, feeling the bladder has not emptied).

The trials in this guide use the IPSS. It asks about seven symptoms (frequency, urgency, getting up at night, incomplete emptying, stopping and starting, weak stream, and pushing or straining), and the total runs from 0 to 35. Higher means worse. The label trials enrolled men with moderate to severe symptoms, who started at about 17 to 18 points. A fall of a few points is the usual size of benefit for BPH tablets, so it helps to read the results as points on this scale rather than as percentages.

The four ways tadalafil is labelled

The US Cialis label lists three conditions and four dosing patterns. Only the last two are the subject of this guide.

UseLabel doseTiming
ED, as neededStart 10 mg; range 5 to 20 mgBefore sex, no more than once a day
ED, once dailyStart 2.5 mg; may increase to 5 mgSame time every day
BPH symptoms5 mgSame time every day
ED and BPH together5 mgSame time every day, regardless of when you have sex

Two details stand out. For BPH there is no 2.5 mg starting step in men with normal kidneys, and in the ED and BPH trial 2.5 mg did not significantly improve the IPSS. And there is no as-needed option for BPH: the urinary benefit was tested only with a tablet every day. Tablets may be taken with or without food, and the label says not to split them.

How much daily 5 mg helps urinary symptoms

The label reports two 12-week trials in men with BPH (Studies J and K) and one in men with both ED and BPH (Study L). The men were 63 years old on average, and the trials included men with diabetes, high blood pressure and other heart disease.

TrialMen (placebo / tadalafil 5 mg)Starting IPSSFall on placeboFall on tadalafil 5 mgp-value
Study J (BPH)205 / 20517.1 / 17.32.24.8<0.001
Study K (BPH)164 / 16016.6 / 17.13.65.60.004
Study L (ED and BPH)193 / 20618.2 / 18.53.86.1<0.001
Grouped bar chart of the fall in total IPSS after 12 weeks in the Cialis label trials. Study J (BPH): placebo 2.2 points, tadalafil 5 mg 4.8 points. Study K (BPH): placebo 3.6, tadalafil 5.6. Study L (ED and BPH): placebo 3.8, tadalafil 6.1. All differences were statistically significant.
Figure 1. Fall in prostate symptom score after 12 weeks on tadalafil 5 mg daily or placebo in the three US label trials. The extra benefit over placebo was 2.0 to 2.6 points. Source: Cialis label, Tables 19 and 21.

Placebo also lowered scores, by 2.2 to 3.8 points, so the fair way to read the result is the gap: 2.6 points in Study J, 2.0 in Study K and 2.3 in Study L. Benefit showed up early. In Study K the score was lower at the first visit at 4 weeks, and in Study L it was lower at the first visit at week 2.

What it does for erections when you have both

Study L randomised 606 men with both conditions to placebo, 2.5 mg or 5 mg daily. ED ranged from mild to severe. The co-primary results for 5 mg against placebo were:

Measure at week 12PlaceboTadalafil 5 mg dailyp-value
IIEF erectile function score, change (0 to 30 scale)+1.9 (n=188)+6.5 (n=202)<0.001
IIEF erectile function score at the end17.622.9
Share of sex attempts where the erection lasted (SEP3), change+12 points (36% to 48%)+32 points (43% to 72%)<0.001

Timing of sex was not restricted in this trial. That is the practical appeal of the daily tablet for a man with both problems: one tablet a day treats the urinary symptoms and keeps tadalafil in the body, so there is no need to plan around a dose. If you only have ED and no urinary symptoms, the label starts daily dosing at 2.5 mg instead, and as-needed use is also an option. Our comparison of the three ED tablets covers that choice.

Urine flow: the result that did not change

Symptom scores are what men feel. Maximum urine flow rate (Qmax) is what a flow meter measures. In all three label trials, Qmax rose a little in both groups and the difference was not statistically significant:

  • Study J: tadalafil 5 mg +1.6 mL per second, placebo +1.2.
  • Study K: tadalafil 5 mg +1.6, placebo +1.1.
  • Study L: tadalafil 5 mg +1.6, placebo +1.2.

So in the label trials tadalafil eased how men rated their symptoms without a measurable change in flow compared with placebo. The head-to-head trial below did find a significant Qmax gain, so the evidence on flow is mixed. Either way, tadalafil is not a treatment for a blocked bladder (urinary retention). That needs prompt medical care.

Tadalafil versus tamsulosin

Tamsulosin is an alpha-blocker, the usual first tablet for BPH symptoms. Oelke and colleagues ran one of the few trials with both drugs in it: 511 men aged 45 or over with an IPSS of 13 or more were randomised to placebo, tadalafil 5 mg or tamsulosin 0.4 mg once daily for 12 weeks.

Bar chart from Oelke 2012: after 12 weeks, total IPSS fell 2.1 points more than placebo on tadalafil 5 mg daily and 1.5 points more than placebo on tamsulosin 0.4 mg daily. Erectile function score improved 4.0 points versus placebo with tadalafil and did not improve with tamsulosin (minus 0.4).
Figure 2. Urinary symptom benefit of tadalafil and tamsulosin, each against placebo, in the same trial. Only tadalafil improved erectile function (IIEF erectile function domain +4.0 vs placebo; tamsulosin -0.4). Source: Oelke 2012.
Change versus placebo at 12 weeksTadalafil 5 mgTamsulosin 0.4 mg
Total IPSS (points)-2.1 (p=0.001)-1.5 (p=0.023)
BPH Impact Index (points)-0.8 (p=0.003)-0.6 (p=0.026)
Maximum urine flow (mL per second)+2.4 (p=0.009)+2.2 (p=0.014)
IIEF erectile function score (points)+4.0 (p<0.001)-0.4 (p=0.699)

Both drugs beat placebo on urinary symptoms, by numerically similar amounts. Tadalafil also improved erectile function, the IPSS quality-of-life score and a treatment satisfaction score; tamsulosin did not. The authors note the trial was not powered to compare the two drugs with each other, so it does not show that one is better for urinary symptoms. What it does support is a simple point: for a man who is bothered by both problems, tadalafil treats both, and tamsulosin treats one.

Tadalafil and alpha-blockers both widen blood vessels and lower blood pressure. The US label is direct about the BPH case: the combination "is not recommended for the treatment of BPH" because its benefit "has not been adequately studied" and blood pressure may fall. Men already on an alpha-blocker for BPH should stop it at least one day before starting tadalafil daily for BPH, under their doctor's guidance.

The rule is different for ED. A man stable on an alpha-blocker can be prescribed tadalafil for ED, starting at the lowest dose. To show why the label is cautious, one of its clinical pharmacology studies gave a single 20 mg dose of tadalafil to healthy men taking doxazosin 8 mg daily. Standing systolic blood pressure fell a mean of 9.8 mmHg more than with placebo (95% CI 4.1 to 15.5).

Do not stop or swap a prescribed BPH medicine on your own. Some men do better on an alpha-blocker, and the switch is a decision to make with the doctor who prescribed it.

Starting tadalafil with finasteride

Finasteride blocks the conversion of testosterone to DHT. The Cialis label tested whether adding tadalafil 5 mg helps in the first months of finasteride treatment. In a 26-week trial, 696 men with a prostate larger than 30 cc started finasteride 5 mg together with tadalafil 5 mg or with placebo.

Line chart from the Cialis label finasteride study: total IPSS fell 4.0, 5.2 and 5.5 points at weeks 4, 12 and 26 with tadalafil plus finasteride, and 2.3, 3.8 and 4.5 points with placebo plus finasteride. The gap narrowed from 1.7 to 1.4 to 1.0 points.
Figure 3. Tadalafil helps most in the first weeks, while finasteride is still taking effect. This is why the label limits tadalafil with finasteride to up to 26 weeks when starting BPH treatment. Source: Cialis label, Table 20.
Fall in total IPSSPlacebo + finasterideTadalafil + finasterideDifferencep-value
Week 42.34.01.7<0.001
Week 123.85.21.40.001
Week 264.55.51.00.022

The extra benefit was largest early and shrank as finasteride caught up. For this reason the label limits the combination to up to 26 weeks when starting BPH treatment, and says the added benefit of tadalafil beyond 26 weeks is unknown. In the 404 men in this trial who also had ED, the erectile function score rose 4.7 points on tadalafil plus finasteride and stayed flat (0.0) on placebo plus finasteride at week 26. Finasteride itself can affect sex: in the first year of its 4-year PLESS trial, impotence was reported by 8.1% on finasteride and 3.7% on placebo, and decreased libido by 6.4% and 3.4% (no significant difference in years 2 to 4). See our guide to finasteride side effects by dose.

Side effects on daily 5 mg

The label pools the three 12-week BPH trials: 581 men on tadalafil 5 mg and 576 on placebo, mean age 63. Stopping because of side effects happened in 3.6% on tadalafil and 1.6% on placebo. Headache, upper abdominal pain and muscle aches were the reasons given by at least two men.

Grouped bar chart from Cialis label Table 4 (placebo vs tadalafil 5 mg daily): headache 2.3% vs 4.1%, dyspepsia 0.2% vs 2.4%, back pain 1.4% vs 2.4%, nasopharyngitis 1.6% vs 2.1%, pain in extremity 0.0% vs 1.4%, myalgia 0.3% vs 1.2%.
Figure 4. Adverse reactions on daily tadalafil 5 mg in the BPH trials. Discontinuation for adverse events was 3.6% on tadalafil and 1.6% on placebo. Source: Cialis label, Table 4.
Adverse reactionPlacebo (n=576)Tadalafil 5 mg (n=581)
Headache2.3%4.1%
Dyspepsia (indigestion)0.2%2.4%
Back pain1.4%2.4%
Nasopharyngitis1.6%2.1%
Diarrhoea1.0%1.4%
Pain in arm or leg0.0%1.4%
Myalgia (muscle aches)0.3%1.2%
Dizziness0.5%1.0%

These rates are lower than in the as-needed ED trials at 10 to 20 mg, which fits the lower daily dose. The back and muscle pain is typical of tadalafil. The label describes it as usually starting 12 to 24 hours after a dose, felt in the lower back, buttocks or thighs, worse lying down, and typically settling within 48 hours. In studies of the daily tablet, back pain and muscle aches were generally mild or moderate and fewer than 1% of men stopped for them.

Less common but serious: seek urgent care for an erection lasting more than 4 hours, sudden loss of vision in one or both eyes, or sudden loss of hearing. These are listed in the label's warnings for all PDE5 inhibitors.

Who must not take tadalafil

The US label lists three contraindications:

  • Any form of nitrate, taken regularly or now and then (for example glyceryl trinitrate spray or tablets, isosorbide mononitrate). Tadalafil increases the blood pressure drop from nitrates. If a man on tadalafil has chest pain needing a nitrate in an emergency, the label says at least 48 hours should pass after the last dose, under close medical supervision.
  • Guanylate cyclase stimulators such as riociguat, used for pulmonary hypertension.
  • A known serious allergy to tadalafil (Cialis or Adcirca).

The label also says tadalafil is not recommended for men with a heart attack in the last 90 days, unstable angina or angina during sex, NYHA class 2 or worse heart failure in the last 6 months, uncontrolled arrhythmias, low blood pressure (below 90/50 mmHg) or uncontrolled high blood pressure, or a stroke in the last 6 months. These groups were not studied. It should not be used by men for whom sexual activity is inadvisable because of their heart condition. Use is also not recommended in severe liver impairment or in hereditary retinal disorders such as retinitis pigmentosa. Men with aortic stenosis or other outflow obstruction, or with severely impaired autonomic control of blood pressure, may be particularly sensitive to vasodilators. Men who have already had NAION (sudden sight loss from reduced blood flow to the optic nerve) are at higher risk of it happening again; the label says PDE5 inhibitors should be used with caution in them and only when the expected benefit outweighs the risk.

Kidneys, liver and other medicines

Because the daily tablet keeps tadalafil in the blood all the time, the label asks doctors to think about interactions more carefully than with occasional use.

SituationLabel rule for daily use in BPH or ED and BPH
Creatinine clearance 30 to 50 mL/minStart 2.5 mg daily; may increase to 5 mg based on response
Creatinine clearance below 30 mL/min or on dialysisDaily use not recommended
Mild or moderate liver impairmentNot extensively studied; caution
Severe liver impairmentNot recommended
Potent CYP3A4 inhibitors (for example ketoconazole, itraconazole, ritonavir)Maximum 2.5 mg daily
Rifampin and other CYP3A4 inducersTadalafil levels fall (rifampin cut exposure by 88%); no dose change set, but less effect is expected
Alpha-blockersNot recommended together for BPH
Other blood pressure tabletsDiscuss the added blood pressure lowering with your doctor
Alcohol5 units or more can add to dizziness and a drop in standing blood pressure
Other ED medicines or another PDE5 inhibitorNot studied in combination; do not combine

That last row includes products such as Sildalist, which combine sildenafil and tadalafil. Our Sildalist guide explains why the labels advise against it.

Check the cause before treating

Urinary symptoms in older men are not always BPH. The label says that before starting tadalafil for BPH, doctors should consider other urological conditions that can cause similar symptoms, and it notes that prostate cancer and BPH may coexist. Your doctor may ask about your history, examine you, test your urine and talk to you about a PSA blood test.

See a doctor promptly, rather than self-treating, if you have blood in the urine, pain or fever with urinary symptoms, you cannot pass urine at all, or symptoms came on suddenly. ED deserves a check-up too, and our guide to what an online ED consultation should ask lists the questions that matter.

Where guidelines disagree

Tadalafil 5 mg is licensed for BPH symptoms in the US and in the European Union, where the Cialis summary of product characteristics lists "treatment of the signs and symptoms of benign prostatic hyperplasia in adult males". Whether doctors are advised to use it is a separate question.

  • United Kingdom. NICE guideline CG97 (updated June 2015), recommendation 1.4.11: "Do not offer phosphodiesterase-5 inhibitors solely for the purpose of treating LUTS in men, except as part of a randomised controlled trial." LUTS means lower urinary tract symptoms. The wording targets men who want treatment only for urinary symptoms.
  • United States. Daily tadalafil 5 mg is an FDA-labelled option for BPH symptoms, and for ED and BPH together.

A reasonable reading of both: tadalafil makes the most sense for men who have both ED and urinary symptoms, or who cannot take an alpha-blocker. For urinary symptoms alone, an alpha-blocker is the usual first choice, and tadalafil is one of several alternatives your doctor may weigh.

What it costs in the US

Generic tadalafil 5 mg is inexpensive at pharmacy cost. The US Medicaid survey of what pharmacies pay (NADAC) for the week of 14 October 2026:

Generic tabletNADAC per unit30-day supply at one a day
Tadalafil 5 mg tablet$0.10319$3.10
Tamsulosin 0.4 mg capsule$0.04997$1.50

NADAC is what pharmacies pay for the drug, not what you pay at the counter, which adds dispensing fees and markup. If you have insurance, ask your plan whether cover for tadalafil depends on the diagnosis on the prescription.

Generic tadalafil 5 mg from SafeRxPills

We sell two generic tadalafil 5 mg tablets made in India: Tadaflo 5 by Cipla and Vidalista 5 by Centurion Laboratories. We have a commercial interest in them, so it is fair to be clear about what they are and are not:

  • They contain the same active ingredient and strength as Cialis 5 mg, but they are not FDA-approved products. A PubMed search found no published bioequivalence study of either brand against Cialis.
  • Tadalafil needs a prescription in the US, Canada and Australia. In the UK, Cialis Together (tadalafil 10 mg) can be supplied by a pharmacist for ED, but other strengths, including daily 5 mg, still need a prescription. Daily use for BPH should start after a doctor has checked the cause of your symptoms and your heart, blood pressure, kidneys and other medicines.
  • If you take an alpha-blocker, nitrates, riociguat or a potent CYP3A4 inhibitor, talk to your doctor before ordering.

For more on the tadalafil brands we stock, see Vidalista vs Cialis and Tadalista strengths compared. US customers can see every tadalafil strength we stock, with its price per tablet, on our generic Cialis page for US buyers. For doses above the label, see our review of high-dose tadalafil.

How to take it day to day

  • One 5 mg tablet at about the same time each day, with or without food. Do not split it.
  • Give it a fair trial. In the label trials urinary scores improved from the first visit (2 to 4 weeks), and the trials ran for 12 weeks.
  • If you miss a dose, the patient information says you may take it when you remember, but do not take more than one dose in a day.
  • Keep the dose at 5 mg. Taking extra as-needed tablets on top of the daily dose is not covered by the label.
  • Tell any doctor treating you for chest pain that you take tadalafil every day, because it affects whether nitrates can be given.

Questions to ask your doctor

  • Are my urinary symptoms from BPH, or could something else be causing them? Do I need a PSA test?
  • Would an alpha-blocker, tadalafil or finasteride suit me best, given my prostate size and whether I also have ED?
  • I already take an alpha-blocker. Should I stop it before starting tadalafil, and how?
  • Is my kidney function normal enough for 5 mg, or should I start at 2.5 mg?
  • Do any of my other medicines, including heart tablets, antifungals or HIV medicines, change the dose?
  • When should we review whether it is working?

Sources

  1. CIALIS (tadalafil) tablets, US prescribing information. Eli Lilly and Company / Lilly USA, LLC. DailyMed, effective June 2026. Sections 1, 2, 4, 5, 6.1 (Table 4), 7, 12.2, 14.3 (Tables 19 and 20) and 14.4 (Tables 21 and 22), and Patient Information.
  2. CIALIS summary of product characteristics, European Medicines Agency (Eli Lilly Nederland B.V.), section 4.1.
  3. Oelke M, Giuliano F, Mirone V, et al. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. European Urology. 2012. PMID 22297243.
  4. National Institute for Health and Care Excellence. Lower urinary tract symptoms in men: management. Clinical guideline CG97. Published 23 May 2010, last updated 3 June 2015. Recommendation 1.4.11.
  5. PROSCAR (finasteride) tablets, US prescribing information, Organon. DailyMed, effective March 2026. Section 6.1, Table 1 (PLESS).
  6. Medicines and Healthcare products Regulatory Agency. MHRA reclassifies Cialis Together tablets to a pharmacy medicine. 14 March 2023. GOV.UK
  7. Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC), week of 14 October 2026: tadalafil 5 mg tablet, tamsulosin HCl 0.4 mg capsule.

This guide is for information and does not replace advice from a doctor who knows your medical history. Do not start, stop or combine prostate or ED medicines without medical advice.

?Frequently Asked Questions

Is tadalafil approved for an enlarged prostate?

Yes. The US Cialis label lists three uses: erectile dysfunction, the signs and symptoms of benign prostatic hyperplasia (BPH), and ED and BPH together. The EU label also includes BPH symptoms. For BPH the dose is 5 mg once a day.

How much does tadalafil 5 mg improve BPH symptoms?

In three 12-week US label trials, the prostate symptom score (IPSS, 0 to 35) fell by 4.8 to 6.1 points on tadalafil 5 mg daily and by 2.2 to 3.8 points on placebo. The extra benefit over placebo was 2.0 to 2.6 points.

Does daily tadalafil help erections and urinary symptoms at the same time?

In the label trial of men with both conditions, tadalafil 5 mg daily lowered the IPSS by 6.1 points versus 3.8 on placebo and raised the erectile function score by 6.5 points versus 1.9. The share of attempts where the erection lasted rose from 43% to 72% on tadalafil, against 36% to 48% on placebo.

How long does tadalafil take to work for BPH?

In the label trials, symptom scores were lower than placebo at the first scheduled visit: week 4 in one BPH trial and week 2 in the ED and BPH trial. The trials ran for 12 weeks, so that is a fair period to judge it.

Is tadalafil better than tamsulosin for BPH?

Not clearly. In a trial of 511 men, both lowered the IPSS more than placebo (by 2.1 and 1.5 points) and raised urine flow by similar amounts. Only tadalafil improved erectile function. The trial was not designed to compare the two drugs directly.

Can I take tadalafil with tamsulosin?

For BPH, the US label says the combination is not recommended, because it has not been adequately studied and blood pressure may fall. Men on an alpha-blocker for BPH should stop it at least one day before starting daily tadalafil, under medical advice. For ED alone, a man stable on an alpha-blocker may start tadalafil at the lowest dose.

Can tadalafil be taken with finasteride?

Yes. When BPH treatment is started with both, the label recommends tadalafil 5 mg daily for up to 26 weeks. The extra benefit of tadalafil fell from 1.7 points at week 4 to 1.0 point at week 26, and its benefit beyond 26 weeks is unknown.

What are the side effects of tadalafil 5 mg daily?

In the BPH trials the most common were headache (4.1% vs 2.3% on placebo), indigestion (2.4% vs 0.2%), back pain (2.4% vs 1.4%) and nose and throat infection (2.1% vs 1.6%). Stopping due to side effects was 3.6% on tadalafil and 1.6% on placebo.

Who should not take tadalafil for BPH?

Men using any nitrate, a guanylate cyclase stimulator such as riociguat, or with a serious allergy to tadalafil must not take it. The label does not recommend it after a recent heart attack or stroke, with unstable angina, significant heart failure, uncontrolled blood pressure or arrhythmia, severe liver disease, retinitis pigmentosa, or a creatinine clearance below 30 mL/min for daily use.

Does NICE recommend tadalafil for urinary symptoms?

No. NICE guideline CG97 (recommendation 1.4.11) says not to offer phosphodiesterase-5 inhibitors solely to treat lower urinary tract symptoms in men, except in a randomised trial. In the US, daily tadalafil is an FDA-labelled BPH treatment.

Is generic tadalafil 5 mg the same as Cialis 5 mg?

FDA-approved US generics must show bioequivalence to Cialis. The Indian brands we sell, Tadaflo 5 (Cipla) and Vidalista 5 (Centurion), contain tadalafil 5 mg but are not FDA-approved, and we found no published bioequivalence study of them. Daily use for BPH should start after a doctor's assessment.

S

SafeRxPills Pharmacy Team

Pharmacist, Content, B.Pharm, M.Pharm, Rajiv Gandhi University

Pharmacist writing on antiparasitic, ophthalmic and dermatological generics. Focuses on what the regulatory labelling and published evidence actually support.

Comments (0)

Leave a Comment

No comments yet. Be the first to share your thoughts!